Corcept Therapeutics's total assets for Q3 2024 were $784.26M, an increase of 9.75% from the previous quarter. CORT total liabilities were $145.42M for the fiscal quarter, a 22.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.